![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 32029 |
FusionGeneSummary for RPRD1B_ANKRD17 |
![]() |
Fusion gene information | Fusion gene name: RPRD1B_ANKRD17 | Fusion gene ID: 32029 | Hgene | Tgene | Gene symbol | RPRD1B | ANKRD17 | Gene ID | 58490 | 26057 |
Gene name | regulation of nuclear pre-mRNA domain containing 1B | ankyrin repeat domain 17 | |
Synonyms | C20orf77|CREPT|K-H|Kub5-Hera|NET60|dJ1057B20.2 | GTAR|MASK2|NY-BR-16 | |
Cytomap | 20q11.23 | 4q13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | regulation of nuclear pre-mRNA domain-containing protein 1BKu70-binding protein 5-Heracell-cycle related and expression-elevated protein in tumor | ankyrin repeat domain-containing protein 17gene trap ankyrin repeat proteinserologically defined breast cancer antigen NY-BR-16 | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | Q9NQG5 | O75179 | |
Ensembl transtripts involved in fusion gene | ENST00000373433, ENST00000471511, | ENST00000358602, ENST00000509867, ENST00000330838, ENST00000514252, | |
Fusion gene scores | * DoF score | 6 X 3 X 4=72 | 8 X 14 X 3=336 |
# samples | 6 | 18 | |
** MAII score | log2(6/72*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(18/336*10)=-0.900464326449086 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: RPRD1B [Title/Abstract] AND ANKRD17 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | RPRD1B | GO:0008284 | positive regulation of cell proliferation | 22264791 |
Hgene | RPRD1B | GO:0010564 | regulation of cell cycle process | 22264791 |
Hgene | RPRD1B | GO:0045944 | positive regulation of transcription by RNA polymerase II | 22264791 |
Tgene | ANKRD17 | GO:0042742 | defense response to bacterium | 23711367 |
Tgene | ANKRD17 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 22328336 |
Tgene | ANKRD17 | GO:0045087 | innate immune response | 23711367 |
Tgene | ANKRD17 | GO:1900245 | positive regulation of MDA-5 signaling pathway | 22328336 |
Tgene | ANKRD17 | GO:1900246 | positive regulation of RIG-I signaling pathway | 22328336 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | LD | BRCA | TCGA-C8-A1HN-01A | RPRD1B | chr20 | 36694658 | + | ANKRD17 | chr4 | 73964237 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000373433 | ENST00000358602 | RPRD1B | chr20 | 36694658 | + | ANKRD17 | chr4 | 73964237 | - |
Frame-shift | ENST00000373433 | ENST00000509867 | RPRD1B | chr20 | 36694658 | + | ANKRD17 | chr4 | 73964237 | - |
Frame-shift | ENST00000373433 | ENST00000330838 | RPRD1B | chr20 | 36694658 | + | ANKRD17 | chr4 | 73964237 | - |
5CDS-intron | ENST00000373433 | ENST00000514252 | RPRD1B | chr20 | 36694658 | + | ANKRD17 | chr4 | 73964237 | - |
intron-3CDS | ENST00000471511 | ENST00000358602 | RPRD1B | chr20 | 36694658 | + | ANKRD17 | chr4 | 73964237 | - |
intron-3CDS | ENST00000471511 | ENST00000509867 | RPRD1B | chr20 | 36694658 | + | ANKRD17 | chr4 | 73964237 | - |
intron-3CDS | ENST00000471511 | ENST00000330838 | RPRD1B | chr20 | 36694658 | + | ANKRD17 | chr4 | 73964237 | - |
intron-intron | ENST00000471511 | ENST00000514252 | RPRD1B | chr20 | 36694658 | + | ANKRD17 | chr4 | 73964237 | - |
Top |
FusionProtFeatures for RPRD1B_ANKRD17 |
![]() |
Hgene | Tgene |
RPRD1B | ANKRD17 |
Interacts with phosphorylated C-terminal heptapeptiderepeat domain (CTD) of the largest RNA polymerase II subunitPOLR2A, and participates in dephosphorylation of the CTD by RPAP2.Transcriptional regulator which enhances expression of CCND1.Promotes binding of RNA polymerase II to the CCDN1 promoter and tothe termination region before the poly-A site but decreases itsbinding after the poly-A site. Prevents RNA polymerase II fromreading through the 3' end termination site and may allow it to berecruited back to the promoter through promotion of the formationof a chromatin loop. Also enhances the transcription of a numberof other cell cycle-related genes including CDK2, CDK4, CDK6 andcyclin-E but not CDKN1A, CDKN1B or cyclin-A. Promotes cellproliferation. {ECO:0000269|PubMed:22231121,ECO:0000269|PubMed:22264791, ECO:0000269|PubMed:24399136,ECO:0000269|PubMed:24997600}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for RPRD1B_ANKRD17 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for RPRD1B_ANKRD17 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
RPRD1B | TUBGCP4, TERF2, BRCA1, AARSD1, ARPC4, BAG1, FUBP1, GRPEL1, LPP, NIF3L1, NPLOC4, OGT, OSGEP, PFDN5, PPP1R12A, RANGAP1, RPA1, ACTR2, ACTR3, ALAD, CALU, DPP9, DUS3L, EFTUD1, PPME1, PPP1R7, SURF2, TES, TOM1L1, ZPR1, SAE1, STAT5B, TP53RK, TTLL12, RPA3, RPA2, WWOX, HUWE1, ABCE1, SLC25A41, POLR2E, POLR2G, CTDP1, RPAP2, POLR2A, POLR2M, RPRD1A, POLR2D, RPRD2, RECQL5, POLR2B, POLR2J, SUPT6H, POLR2I, POLR2C, GPN3, POLR2L, POLR2F, ACTL6A, ATP6V1B2, KPNB1, SRM, EWSR1, NEFM, RB1, SUPT5H, RNF168, CEP170P1, LMO2, STRAP, USP47, SNRNP27, ASB6, KLHL20, FGB, GPN1, TRIM25, URI1 | ANKRD17 | BAP1, APC, ITSN2, SIRT7, KIAA0368, ITGA4, ADH6, MDM2, AURKB, CDKN1A, HOXC4, MAGEA1, ZC3H3, FOSL2, SFRP4, LHX9, RBM23, MSH6, NTRK1, FGFR1OP, CAPN1, RPL10, CREB1, FOS, AKAP17A, FGF3, FGF8, STX11, TRIM41, TCEANC2, TGIF2LY, ZNF263, IRF9, CDX1, SIX2, ZNF414, TRMT2A, HOXD4 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for RPRD1B_ANKRD17 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for RPRD1B_ANKRD17 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |